secwatch.observer — SEC 8-K summary
======================================

Issuer:     Sintx Technologies, Inc. (SINT)
CIK:        0001269026
Form:       8-K
Filed at:   2024-01-04T23:59:59+00:00
Accession:  0001493152-24-000514
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SINTX strengthens antipathogenic patent portfolio with six US and three foreign patents in 2023
--------------------------------------------------------------------------------

- Granted six US patents in the last year covering silicon nitride applications: antifungals, antibacterial implants, SARS-CoV-2 inactivation, antiviral compositions, antipathogenic face masks.
- Also received three foreign patents in 2023; 43 patent applications pending worldwide including in US, Asia, Europe, Brazil.
- Patents support commercialization of silicon nitride in agriculture, dentistry, medical implants, durable medical equipment, and PPE.
- NIH-funded commercialization work is ongoing based on coating and composite technologies covered by these patents.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1269026/000149315224000514/0001493152-24-000514-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1269026/000149315224000514/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-000514

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer